Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
remedent from Gent, company number BE0474973168, closed financial year 2025 with a result of € -385,552 after tax. For that financial year remedent recorded revenue of € 62,168 and equity of € 2.3 million. Compared with financial year 2024, the result moved from € -260,324 to € -385,552. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.
€ 2.3 million
▼ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -385,552
▼ 48 % more loss than in 2024
Profit after tax over the fiscal year.
€ 3,780
▼ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 46,053.
People and assets in 2025
2.6
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 335,069
▼ 11% vs 2024
€ 128,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,936
▲ 246% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.2 million
▼ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 5795 days on average.
€ 370,293
▲ 52% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 401,905 | € 46,112 | € 69,829 | € 62,168 | ▼ 11% |
| Profit after taxes | € 131,864 | € -304,133 | € -260,324 | € -385,552 | ▼ € 125,228 |
| Equity | € 3,206,062 | € 2,901,929 | € 2,641,605 | € 2,256,053 | ▼ 15% |
| Total debts | € 1,422,603 | € 1,543,815 | € 1,827,055 | € 1,780,278 | ▼ 3% |
| Cash | € 2,519 | € 27,690 | € 4,775 | € 3,780 | ▼ 21% |
| Retained profit | € 996,062 | € 691,929 | € 431,605 | € 46,053 | ▼ 89% |
| Balance sheet total | € 4,643,123 | € 4,445,745 | € 4,468,660 | € 4,036,331 | ▼ 10% |
| Employees (FTE) | 3.1 | 3 | 3 | 2.6 | ▼ 0.4 |
Key figures of remedent, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to remedent?
What happened at remedent in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 385,552. Source: NBB ↗
- Remedent Professional Holdings Inc stepped down as director. NBB
- Guy De Vreese stepped down as director. NBB
- Remedent Professional Holdings Inc became a director. NBB
- Guy De Vreese became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 131,864 profit in 2022 to € 385,552 loss in 2025.
Paid € 2,555 in corporate taxes since 2022.
Best year ever: 2022, with € 131,864 profit.
A new publication or filing at remedent? We notify you, reason included.
Follow remedentDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 50% of Biotech Dental Benelux, 24.2% of Metrics in Balance, 21.5% of GlamSmile Dental Technology and 2.4% of Condor Technologies itself.
Directors
According to the 2025 annual accounts
Remedent Professional Holdings Inc
Director · represented by Philippe Van Acker
since 2020 · until 2025
Guy De Vreese
Managing director
Also active at: Shane Invest, LAUSHA, Condor Technologies, Biotech Dental Benelux, Metrics in Balance, Aesthics, DNA Talks, ELEMENTAL +1 more
since 2019 · until 2025
Establishments
Establishment units
Physical locations of this company
Zuiderlaan 1-3 box 8
9000 Gent
Zuiderlaan 1-3
9000 Gent
Active since 1 March 2009
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →PAEPSEM
€ 788,648 revenue · 2025
DE COLVENAER
€ 126,511 revenue · 2025
Condor Technologies same network
€ 14,615 revenue · 2024
Pexip Belgium
€ 1.4 million gross margin · 2025
Biotech Dental Benelux same network
€ 202,087 gross margin · 2024
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0474.973.168
- VAT number
- BE 0474.973.168
- Registered office
- Zuiderlaan 1-3 bus 8, 9000 Gent
- Names & denominations
- remedent
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 June 2001
- Peppol
- Not registered
- Contact
- remedent.be
- Activities · NACE
Vervaardiging van overige farmaceutische producten
Vervaardiging van overige farmaceutische preparaten
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden